AlloVir, Inc.
Hedge Funds Holdings
Last updated:
AlloVir, Inc.‘s stocks are currently a part of 53 hedge funds’ portfolios, which represents 39.18% of the total amount of its stocks outstanding. This makes up a total of 30.03M shares of AlloVir, Inc.. Compared to the previous quarter, the number fell by -20.21% or -7.60M shares fewer. As for the holding position changes, 32.08% (17) of current hedge fund investors increased the number of shares held, 39.62% (21) of current holders sold a part of the shares held, and 7.55% (4) closed the holdings completely. 4 hedge funds are new holders of AlloVir, Inc. stock in Q1 2023, it is 7.55% of total holders.
Hedge funds holding AlloVir (Q1 2019 – Q1 2023)
| Q1 2019 | 1 |
|---|---|
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 1 |
| Q3 2020 | 60 |
| Q4 2020 | 70 |
| Q1 2021 | 72 |
| Q2 2021 | 82 |
| Q3 2021 | 74 |
| Q4 2021 | 80 |
| Q1 2022 | 84 |
| Q2 2022 | 84 |
| Q3 2022 | 84 |
| Q4 2022 | 86 |
| Q1 2023 | 53 |
Hedge funds changes in AlloVir positions (Q1 2019 – Q1 2023)
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2019 | 0 | 0 | 0 | 0 | 1 |
| Q3 2019 | 0 | 0 | 0 | 0 | 1 |
| Q4 2019 | 0 | 0 | 0 | 0 | 1 |
| Q1 2020 | 0 | 0 | 0 | 0 | 1 |
| Q2 2020 | 0 | 0 | 0 | 0 | 1 |
| Q3 2020 | 59 | 0 | 0 | 0 | 1 |
| Q4 2020 | 22 | 23 | 14 | 12 | -1 |
| Q1 2021 | 13 | 38 | 9 | 11 | 1 |
| Q2 2021 | 21 | 25 | 25 | 11 | 0 |
| Q3 2021 | 9 | 29 | 22 | 16 | -2 |
| Q4 2021 | 17 | 24 | 28 | 12 | -1 |
| Q1 2022 | 15 | 28 | 26 | 10 | 5 |
| Q2 2022 | 14 | 30 | 24 | 12 | 4 |
| Q3 2022 | 16 | 35 | 22 | 17 | -6 |
| Q4 2022 | 15 | 36 | 19 | 13 | 3 |
| Q1 2023 | 4 | 17 | 21 | 4 | 7 |
Hedge funds changes in AlloVir stock options (Q1 2019 – Q1 2023)
| Q1 2019 | 0 | 0 |
|---|---|---|
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 4,000 |
| Q4 2020 | 19,000 | 7,000 |
| Q1 2021 | 5,239,000 | 44,000 |
| Q2 2021 | 1,000 | 1,000 |
| Q3 2021 | 1,330,000 | 2,000 |
| Q4 2021 | 647,000 | 321,000 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 129,000 | 0 |
| Q3 2022 | 267,000 | 180,000 |
| Q4 2022 | 110,158 | 81,054 |
| Q1 2023 | 43,371,000 | 394,000 |